{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:53:25Z","timestamp":1782921205162,"version":"3.54.5"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Obesity and type 2 diabetes are major global health concerns associated with substantial clinical and economic burdens. Bariatric metabolic surgery (BMS) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective interventions, but their long-term impact on health care utilization costs remains incompletely understood.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare short- and long-term health care utilization costs among patients with obesity and diabetes treated with GLP-1RAs vs those who underwent BMS.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This observational, retrospective cohort study used electronic medical records from Clalit Health Services, the largest health care organization in Israel. Adults (aged \u226524 years) with obesity (body mass index [BMI] \u226530) and diabetes who underwent their first BMS or initiated GLP-1RA therapy between January 1, 2010, and December 31, 2022, were identified. Propensity score matching yielded 2721 matched pairs, who were followed up for up to 12.5 years (mean [SD], 6.5 [3.5] years), through December 31, 2023. Data cleaning and analyses were conducted from June to October 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Treatment with GLP-1RAs or BMS.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Health care utilization costs incurred by the health system, excluding costs of the index interventions. Attributable costs were estimated using a difference-in-differences approach and modeled with multivariable linear regression.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The matched cohort included 5442 adults (mean [SD] age, 51 [10] years; 3243 women [59.6%]; mean [SD] BMI, 40.5 [6.0]). Mean (SD) monthly follow-up costs were higher among patients treated with GLP-1RAs than those who underwent BMS ($415.3 [$746.7] vs $304.9 [$628.5]). The adjusted difference-in-differences method showed $109.0 higher monthly costs per patient for GLP-1RA treatment (SE\u2009=\u2009$17.0;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), associated primarily with hospitalization costs ($43.9; SE\u2009=\u2009$13.3;\n P<\/jats:italic>\n \u2009=\u2009.001) and non\u2013GLP-1 medication costs ($52.5; SE\u2009=\u2009$4.4;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Most cost differences accrued within the first 4 years. BMS was associated with greater early reductions in BMI and hemoglobin A\n 1c<\/jats:sub>\n , whereas GLP-1RA treatment showed more modest but sustained effects.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cohort study found that, among adults with obesity and diabetes, health care utilization costs were higher with GLP-1RA treatment than with BMS, excluding intervention costs, largely reflecting differences in early clinical trajectories. These findings suggest that, among patients eligible for both interventions, BMS may confer combined clinical and economic advantages over long-term follow-up.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.21305","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:36:07Z","timestamp":1782920167000},"page":"e2621305","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery"],"prefix":"10.1001","volume":"9","author":[{"given":"Yael","family":"Wolff Sagy","sequence":"first","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan Ernest","family":"Winter","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiessam","family":"Abu Ahmad","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"},{"name":"Braun School of Public Health, Hebrew University\u2013Hadassah, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Battat","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Arbel","sequence":"additional","affiliation":[{"name":"Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel"},{"name":"Community Medical Services Division, Clalit Health Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Reges","sequence":"additional","affiliation":[{"name":"Department of Health System Management, Ariel University, Ariel, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Dicker","sequence":"additional","affiliation":[{"name":"School of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Internal Medicine Department D and Obesity Clinic, Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Lavie","sequence":"additional","affiliation":[{"name":"Branch of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel"},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion\u2013Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"11","key":"zoi260592r1","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1007\/s00464-024-11191-1","article-title":"A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?","volume":"38","author":"Docimo","year":"2024","journal-title":"Surg Endosc"},{"issue":"10","key":"zoi260592r2","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.7326\/ANNALS-24-03161","article-title":"Association of overweight and obesity with financial burden.","volume":"178","author":"Bajaj","year":"2025","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi260592r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15392","article-title":"Bariatric metabolic surgery vs glucagon-like peptide-1 receptor agonists and mortality.","volume":"7","author":"Dicker","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi260592r6","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s41591-024-03052-0","article-title":"Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure.","volume":"30","author":"Wolff Sagy","year":"2024","journal-title":"Nat Med"},{"key":"zoi260592r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103213","article-title":"Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study.","volume":"83","author":"Wolff Sagy","year":"2025","journal-title":"EClinicalMedicine"},{"key":"zoi260592r8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/CLEP.S230677","article-title":"Combining inpatient and outpatient data for diagnosis of non-valvular atrial fibrillation using electronic health records: a validation study.","volume":"12","author":"Reges","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"8","key":"zoi260592r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25657","article-title":"Health care utilization in the 6 months following SARS-CoV-2 infection.","volume":"5","author":"Tartof","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi260592r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/0034-6527.00321","article-title":"Semiparametric difference-in-differences estimators.","volume":"72","author":"Abadie","year":"2005","journal-title":"Rev Econ Stud"},{"issue":"10031","key":"zoi260592r12","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","article-title":"Management of obesity.","volume":"387","author":"Bray","year":"2016","journal-title":"Lancet"},{"key":"zoi260592r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.12.018","author":"Drucker","year":"2024","journal-title":"Cell Metab"},{"issue":"24","key":"zoi260592r14","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1001\/jama.2022.9009","article-title":"Association of bariatric surgery with cancer risk and mortality in adults with obesity.","volume":"327","author":"Aminian","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"zoi260592r15","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/oby.23812","article-title":"Long-term cancer outcomes after bariatric surgery.","volume":"31","author":"Adams","year":"2023","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"zoi260592r16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials.","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"zoi260592r17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010453","article-title":"Trends and outcomes associated with bariatric surgery and pharmacotherapies with weight loss effects among patients with heart failure and obesity.","volume":"17","author":"Mentias","year":"2024","journal-title":"Circ Heart Fail"},{"issue":"9","key":"zoi260592r18","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1007\/s12325-025-03285-6","article-title":"Body mass index progression, development of complications and healthcare costs over 8 years in UK individuals living with overweight\/obesity.","volume":"42","author":"Busetto","year":"2025","journal-title":"Adv Ther"},{"key":"zoi260592r19","volume-title":"The Israeli Healthcare System: An Overview","author":"Chernichovsky","year":"2018"},{"key":"zoi260592r3","unstructured":"Sanchez J, Lundberg A, Jones WN, et al. Comparative cost-effectiveness analysis of bariatric surgery and GLP-1 receptor agonists for the management of obesity. PowerPoint Presentation. Northwestern University. Accessed August 17, 2025. https:\/\/www.surgery.northwestern.edu\/docs\/edelstone-bendix-research-poster\/2024-posters\/Sanchez-Joseph.pdf"},{"key":"zoi260592r4","unstructured":"ATC\/DDD Index. World Health Organization and Norwegian Institute of Public Health. Accessed September 14, 2024. https:\/\/atcddd.fhi.no\/atc_ddd_index\/"},{"key":"zoi260592r9","unstructured":"Characterization and classification of geographical units by the socio-economic level of the population, 2019. Israel Central Bureau of Statistics. Accessed July 28, 2025. https:\/\/www.cbs.gov.il\/en\/publications\/Pages\/2023\/socio-2019-e.aspx"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2851020\/wolff_sagy_2026_oi_260592_1782838590.37587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:36:20Z","timestamp":1782920180000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2851020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.21305","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}